Zobrazeno 1 - 10
of 174
pro vyhledávání: '"M. Wojdyla"'
Autor:
Konstantin A. Krychtiuk, MD, PhD, Renato D. Lopes, MD, PhD, MHS, Daniel M. Wojdyla, MS, Shaun G. Goodman, MD, MSc, Ronald Aronson, MD, Stephan Windecker, MD, Roxana Mehran, MD, Christopher B. Granger, MD, John H. Alexander, MD, MHS, Karen P. Alexander, MD
Publikováno v:
JACC: Advances, Vol 3, Iss 11, Pp 101335- (2024)
Background: Patients with atrial fibrillation (AF) after an acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) with multiple comorbidities are at increased risk for bleeding and ischemic events. Objectives: This
Externí odkaz:
https://doaj.org/article/65cf2f5f51084fe683a7538908098567
Autor:
John H Alexander, Christopher B Granger, Sigrun Halvorsen, Stephan Windecker, Dragos Vinereanu, Daniel M Wojdyla, Roxana Mehran, Shaun Goodman, Renato Lopes, Robert C. Welsh, Payam Dehghani, Ronald Aronson, Amit N Vora, Alexander Parkhomenko
Publikováno v:
Open Heart, Vol 9, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/df9d747ec8bc46c0a31fa9a683c18973
Autor:
Marat Fudim, Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, Dragos Vinereanu, Sigrun Halvorsen, M. Cecilia Bahit, Christopher B. Granger, Renato D. Lopes
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 24 (2021)
Externí odkaz:
https://doaj.org/article/1adde017719f45b9b6bbc999f50cbd2e
Autor:
Sadiya S. Khan, Courtney Page, Daniel M. Wojdyla, Yosef Y. Schwartz, Philip Greenland, Michael J. Pencina
Publikováno v:
Circulation. 146:587-596
Background: Understanding the predictive utility of previously derived polygenic risk scores (PRSs) for long-term risk of coronary heart disease (CHD) and its additive value beyond traditional risk factors can inform prevention strategies. Methods: D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038905595b63da883ae67fb491e02458
https://doi.org/10.1161/circulationaha.121.058426
https://doi.org/10.1161/circulationaha.121.058426
Autor:
Sana M. Al-Khatib, Daniel M. Wojdyla, Christopher B. Granger, Lars Wallentin, David A. Garcia, Ziad Hijazi, Claes Held, John H. Alexander, Dragos Vinereanu, Gregory C. Flaker, Elaine M. Hylek, Renato D. Lopes
Publikováno v:
Circulation. 146:958-960
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45fe5df72bdcca34ccf3ae91df741eca
https://doi.org/10.1161/circulationaha.122.059438
https://doi.org/10.1161/circulationaha.122.059438
Autor:
Peter W. Groeneveld, Adam J. Nelson, Sunil V. Rao, Pratik Manandhar, Robert W. Yeh, Alexander C. Fanaroff, Paul N. Fiorilli, Jay Giri, Stephen W. Waldo, Daniel M. Wojdyla, Tracy Y. Wang, Ashwin S. Nathan
Publikováno v:
Journal of the American College of Cardiology. 78:2213-2217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc30ee20afab7c9a969f3a9e70b42912
https://doi.org/10.1016/j.jacc.2021.09.862
https://doi.org/10.1016/j.jacc.2021.09.862
Autor:
P Guimaraes, D M Wojdyla, J H Alexander, S G Goodman, R Aronson, S Windecker, R Mehran, C B Granger, R D Lopes
Publikováno v:
European Heart Journal. 43
Background Patients with atrial fibrillation (AF) and concomitant coronary artery disease are at increased risk for poor outcomes. Less is known about specific causes of death in this population. Methods We describe specific causes of death among pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe526c633666e3c7918d2ecdec1a3749
https://doi.org/10.1093/eurheartj/ehac544.626
https://doi.org/10.1093/eurheartj/ehac544.626
Autor:
Siyun Yang, Elizabeth Lorenzi, Daniel M. Wojdyla, Fan Li, Laine Thomas, Georgia Papadogeorgou
Publikováno v:
Statistics in Medicine
A common goal in comparative effectiveness research is to estimate treatment effects on pre-specified subpopulations of patients. Though widely used in medical research, causal inference methods for such subgroup analysis remain underdeveloped, parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cfdc0c624b463dac734a6c105e84efb
http://europepmc.org/articles/PMC8360075
http://europepmc.org/articles/PMC8360075
Autor:
Kaiyuan Hua, Jonas Oldgren, Anthony P. Carnicelli, Manesh R. Patel, Lars Wallentin, John H. Alexander, Combine Af Investigators, Christian T. Ruff, Renato D. Lopes, Daniel M. Wojdyla, Robert P. Giugliano, Stuart J Connolly, Christopher B. Granger, John W. Eikelboom, Stefan H. Hohnloser, Hwanhee Hong, David A. Morrow, Jonathan P. Piccini
Publikováno v:
American Heart Journal. 233:48-58
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are the preferred class of medications for prevention of stroke and systemic embolism in patients with atrial fibrillation unless contraindications exist. Five large, international, rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e06f35c3dbc43165734a036e9ee88b15
https://doi.org/10.1016/j.ahj.2020.12.002
https://doi.org/10.1016/j.ahj.2020.12.002
Autor:
Sharon Cresci, Richard G. Bach, Sara Saberi, Anjali Tiku Owens, Neal K. Lakdawala, Ester Kim Nilles, Daniel M. Wojdyla, Amy J. Sehnert, Andrew Wang
Publikováno v:
Journal of the American College of Cardiology. 81:344
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd41733fa02a168cd7185fa57be56750
https://doi.org/10.1016/s0735-1097(23)00788-x
https://doi.org/10.1016/s0735-1097(23)00788-x